Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 October 2012 12 Oktober 2012Press releaseVeterinary World Arthritis Day: 12 October 2012 12 Oktober 2012NewsCorporate European Medicines Agency's conflicts-of-interests handling recognised in European Court of Auditors report 11 Oktober 2012Press releaseCorporateMedicines European Medicines Agency on track to meet core business targets for 2012 10 Oktober 2012Press releaseCorporateMedicines European Medicines Agency releases guideline on medicinal products for the treatment of schizophrenia 9 Oktober 2012NewsHumanRegulatory and procedural guidanceMedicines World Mental Health Day: 10 October 2012 9 Oktober 2012NewsCorporate European Medicines Agency invites feedback on the draft guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis 9 Oktober 2012NewsHumanRegulatory and procedural guidanceMedicines European Medicines Agency publishes active substance list with lead Member State responsible for safety monitoring 5 Oktober 2012NewsCorporateMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-3 October 2012 5 Oktober 2012NewsHumanPharmacovigilance European Medicines Agency website unavailable intermittently Saturday 6 October 4 Oktober 2012NewsCorporateMedicines 1 … 242 243 244 245 246 Page 246 of 384 247 248 249 250 … 384
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 October 2012 12 Oktober 2012Press releaseVeterinary
European Medicines Agency's conflicts-of-interests handling recognised in European Court of Auditors report 11 Oktober 2012Press releaseCorporateMedicines
European Medicines Agency on track to meet core business targets for 2012 10 Oktober 2012Press releaseCorporateMedicines
European Medicines Agency releases guideline on medicinal products for the treatment of schizophrenia 9 Oktober 2012NewsHumanRegulatory and procedural guidanceMedicines
European Medicines Agency invites feedback on the draft guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis 9 Oktober 2012NewsHumanRegulatory and procedural guidanceMedicines
European Medicines Agency publishes active substance list with lead Member State responsible for safety monitoring 5 Oktober 2012NewsCorporateMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-3 October 2012 5 Oktober 2012NewsHumanPharmacovigilance
European Medicines Agency website unavailable intermittently Saturday 6 October 4 Oktober 2012NewsCorporateMedicines